DIRECTIONS
eBio-hub research topics cover an extensive area, which are focused on four main research directions, in line with the Horizon Europe missions, as presented in the diagram.
eBio-hub team foresee to contribute to the development of (1) Molecular diagnostics field through designing, developing and validating patient-tailored interventions and therapeutics, molecular diagnostic tests and assays in the field of infectious disease, endocrinology and cancer (e.g., POC, biosensors, engineering solutions for microbiome studies, etc.,); (2) Nanomedicine field by finding and developing new and intelligent laboratory solutions that may contribute to the advancement of safe, efficient and personalized anticancer therapies, capable to tackle the main challenges faced in academia and clinical practice in cancers management (e.g., biomimetic nanocarriers, intelligent systems for efficient genome editing, transdermal co-delivery systems, etc.,); (3) Transdermal drug delivery field by creating smart devices to support personalized and precision medicine at the point of care, and widening the range of possible treatments and other patient’s needs beyond vaccination (e.g., microneedles approach, POC testing solutions, etc.,); (4) e-Skin/e-Tattoo field through developing new solutions for active monitoring of health conditions (diagnostic) for therapeutic and preventive approaches, capable to overcome the problems associated with blood sample collection and provide higher compliance among various users (e.g., athletes, patients).
